The coverage question everyone's asking — here's the complicated answer.
GLP-1 medications like Ozempic, Wegovy, Mounjaro, and Zepbound have become some of the most-prescribed drugs in the country. Coverage is complicated and varies wildly by plan.
It depends on why it's prescribed and what your specific plan covers.
Ozempic and Mounjaro were originally approved for Type 2 diabetes. When prescribed for that indication, most insurance plans — including commercial employer plans and Medicare Part D — cover them, though cost-sharing varies.
Wegovy and Zepbound are FDA-approved for chronic weight management. Employer health plans are not required to cover weight loss drugs, and many don't. Medicare traditionally excluded obesity drugs, though this is slowly changing.
Coverage for these drugs is expanding rapidly. What wasn't covered last year may be covered now. Always check your current plan documents and call to confirm.